Market closedNon-fractional
Embecta Corp./EMBC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Embecta Corp.
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
Ticker
EMBC
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Parsippany, United States
Employees
2,200
Website
www.embecta.com
Embecta Corp. Metrics
BasicAdvanced
$696M
Market cap
9.88
P/E ratio
$1.22
EPS
0.82
Beta
$0.60
Dividend rate
4.97%
Dividend yield
Price and volume
Market cap
$696M
Beta
0.82
Dividend rate
$0.60
Financial strength
Current ratio
2.287
Quick ratio
1.508
Long term debt to equity
-212.656
Total debt to equity
-215.138
Dividend payout ratio (TTM)
49.00%
Interest coverage (TTM)
1.71%
Management effectiveness
Return on assets (TTM)
9.74%
Return on equity (TTM)
-8.82%
Valuation
Price to earnings (TTM)
9.881
Price to revenue (TTM)
0.612
Price to book
-0.9
Price to tangible book (TTM)
-0.87
Price to free cash flow (TTM)
73.747
Dividend yield (TTM)
4.97%
Growth
Revenue change (TTM)
1.25%
Earnings per share change (TTM)
-25.37%
What the Analysts think about Embecta Corp.
Analyst Ratings
Majority rating from 4 analysts.
Embecta Corp. Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$287M
3.57%
Net income
$29M
43.78%
Profit margin
10.06%
38.95%
Embecta Corp. Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.69
$0.59
$0.61
$0.67
-
Expected
$0.46
$0.40
$0.46
$0.40
$0.46
Surprise
50.00%
48.43%
34.07%
67.50%
-
Embecta Corp. News
AllArticlesVideos
embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
GlobeNewsWire·2 weeks ago
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors
PRNewsWire·2 weeks ago
Embecta (EMBC) CEO on Diabetes Treatment Market
Schwab Network·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Embecta Corp. stock?
Embecta Corp. (EMBC) has a market cap of $696M as of July 05, 2024.
What is the P/E ratio for Embecta Corp. stock?
The price to earnings (P/E) ratio for Embecta Corp. (EMBC) stock is 9.88 as of July 05, 2024.
Does Embecta Corp. stock pay dividends?
Yes, the Embecta Corp. (EMBC) stock pays dividends to shareholders. As of July 05, 2024, the dividend rate is $0.6 and the yield is 4.97%. Embecta Corp. has a payout ratio of 49% on a trailing twelve-month basis.
When is the next Embecta Corp. dividend payment date?
The next Embecta Corp. (EMBC) dividend payment date is unconfirmed.
What is the beta indicator for Embecta Corp.?
Embecta Corp. (EMBC) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Embecta Corp. stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.